Safran SA (SAF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Safran SA (Safran) is a global high-technology group that provides solutions to the aerospace, defense, and security markets. The company’s product portfolio comprises of air conditioning systems, aircraft electronic equipment and critical software, boosters, auxiliary power units, elastomer products, electrical distribution systems, passenger seats, fuel management systems, wheels and brakes, water and waste management systems and helicopter engines. Safran develops electromechanical flight control solutions for various types of aviation platforms such as planes, helicopters, and drones. It also provides engineering, aftermarket, and maintenance, repair and overhaul services. The company has business operations across Americas, Europe, Asia-Pacific, Africa and Middle East. Safran is headquartered in Paris, Ile-de-France, France.
Safran SA Key Recent Developments
Jul 31, 2025: Safran Announces H1 2025 Results
Apr 25, 2025: Safran Announces Q1 2025 Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company
Valneva SE - Key Facts
Valneva SE - Key Employees
Valneva SE - Key Employee Biographies
Valneva SE - Major Products and Services
Valneva SE - History
Valneva SE - Company Statement
Valneva SE - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Company Overview
Valneva SE - Business Description
Other Break-up: Other Non-IFRS 15 Revenue
Performance
Other Break-up: Other Revenues from Contracts with Customers
Performance
Other Break-up: Product Sales
Performance
Geographical Segment: Austria
Performance
Geographical Segment: Canada
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Nordics
Performance
Geographical Segment: Other Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United Kingdom
Performance
Geographical Segment: United States
Performance
R&D Overview
Valneva SE - Corporate Strategy
Valneva SE - SWOT Analysis
SWOT Analysis - Overview
Valneva SE - Strengths
Valneva SE - Weaknesses
Valneva SE - Opportunities
Valneva SE - Threats
Valneva SE - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Valneva SE, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Valneva SE, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Valneva SE, Recent Deals Summary
Section 5 - Company’s Recent Developments
Jun 25, 2026: Valneva Announces Approval Of Resolutions Presented At Its Annual General Meeting
May 28, 2026: Valneva to Participate in Investor Conferences in the United States and Europe
May 13, 2026: Valneva Reports First Quarter 2026 Financial Results and Corporate Updates
May 05, 2026: Valneva to Report First-Quarter 2026 Consolidated Financial Results on May 13, 2026
Mar 26, 2026: Valneva To Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC
Mar 23, 2026: Pfizer and Valneva Lyme Disease Vaccine Candidate Shows Strong Efficacy in Phase 3 VALOR Trial
Mar 18, 2026: Valneva Reports Full Year 2025 Audited Consolidated Financial Results
Feb 20, 2026: Valneva SE Research Update And Financial Outlook
Feb 19, 2026: Valneva’s Lyme disease vaccine offers beacon of hope amid 2025 sales dip
Feb 13, 2026: Valneva Updates Recommendations for Use of IXCHIQ in the United Kingdom
Section 6 - Appendix
Methodology
Ratio Definitions
About the Analyst
Contact the Publisher
Disclaimer
List of Tables
Valneva SE, Key Facts
Valneva SE, Key Employees
Valneva SE, Key Employee Biographies
Valneva SE, Major Products and Services
Valneva SE, History
Valneva SE, Subsidiaries
Valneva SE, Key Competitors
Valneva SE, Ratios based on current share price
Valneva SE, Annual Ratios
Valneva SE, Interim Ratios
Valneva SE, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Valneva SE, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Valneva SE, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Valneva SE, Performance Chart (2021 - 2025)
Valneva SE, Ratio Charts
Valneva SE, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Valneva SE, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026
This product is a company SWOT Analysis. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a company SWOT Analysis. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a company SWOT Analysis. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net